Ipamix

Indapamide, the active ingredient in Ipamix, is a thiazide-like diuretic presented as an oral dosage form for oral use. It is employed to treat hypertension and edema in adult patients, and its pharmacological profile includes inhibition of sodium and chloride reabsorption in the distal convoluted tubule, leading to increased diuresis and reduced peripheral vascular resistance.

GNH USA supplies Ipamix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide is indicated for conditions involving fluid overload and elevated blood pressure.

Hypertension: reduces systolic and diastolic blood pressure. Edema: promotes excretion of excess extracellular fluid. Congestive heart failure: assists in managing fluid retention associated with cardiac dysfunction.

Indapamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Increased frequency of urination. - Electrolyte disturbances such as low potassium. - Nausea or abdominal discomfort.

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance. - Hyponatremia or hyperuricemia leading to gout attacks. - Allergic reactions including rash or angioedema. - Blood dyscrasias such as leukopenia. - Pancreatitis.

When prescribing Indapamide, several safety considerations should be observed.

- Monitor electrolytes: check serum potassium and sodium regularly. - Assess renal function: avoid use in severe renal impairment. - Caution in gout: may increase uric acid levels. - Avoid abrupt discontinuation: taper to prevent rapid blood‑pressure rebound. - Use with caution in hepatic disease: dose adjustment may be required. - Store at ambient temperature: keep in the original container, protect from moisture.

Indapamide can affect the pharmacokinetics or pharmacodynamics of several co‑administered medicines.

Major Interactions (Avoid): - Lithium: risk of lithium toxicity. - NSAIDs: may blunt diuretic effect and impair renal function. - Antidiabetic agents: increased risk of hypoglycaemia. - Cyclosporine: enhanced nephrotoxicity. - Digoxin: may raise serum digoxin levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: potential for excessive hypotension. - Beta‑blockers: additive blood‑pressure lowering. - Corticosteroids: may reduce diuretic efficacy.